Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q4 EPS by 17c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q4 EPS of ($0.29), $0.17 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Piper Sandler Starts The Carlyle Group LP (CG) at Overweight
• Cintas beats estimates but stock edges lower